HIGHMARK, INC. for HIGHMARK INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Health Insurance Tax (HIT Tax); Tax Credits HR 173 Middle Class Health Benefit Tax Repeal Act Introduced January 3, 2-17 by Mike Kelly (R-PA) To amend the Internal Revenue Code of 1986 to repeal the excise tax on high cost employer-sponsored health coverage. HR 246 Introduced January 4, 2017 by Kristi Noem (R-SD) This bill repeals a provision of the Patient Protection and Affordable Care Act that imposes an annual fee on a health insurance provider based on its net premium income. HR 5963 Introduced May 24, 2018 by Kristi Noem (R-SD) To delay the reimposition of the annual fee on health insurance providers until after 2020. S 3063 Introduced June 13, 2018 by John Barrasso (R-WY) A bill to delay the reimposition of the annual fee on health insurance providers until after 2020.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Health Issues HCR
Affordable Care Act (ACA); ACA Regulations; ACA Stabilization; Health Reform; Risk Adjustment; State Flexibility; Opioids; Sober Homes; Marketplace Stability; Individual Market Reform; CREATES Act; Sec. 1332 Waivers; Short Term Limited Duration (STLD): AHPs; Value-based Care; Health Care Costs; Single Payer; Reinsurance; CSRs; 42 CFR Part 2 HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee. HR 2212 CREATES Act Introduced April 27, 2017 by Tom Marino (R-PA) To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products. HR 6082 Overdose Prevention and Patient Safety Act Introduced June 13, 2018 by Markwayne Mullin (R-OK) Amends the Public Health Service Act to permit substance use disorder (SUD) records to be shared among covered entities and Part 2 programs in accordance with the Health Insurance Portability and Accountability Act of 1996 (HIPAA), for the purposes of treatment, payment, and healthcare operations. In order to protect individuals seeking and receiving SUD treatment, the bill enhances the protections on the disclosure of SUD treatment records to non-covered entities and non-Part 2 programs by, except for authorization by court order or by consent of the patient, prohibiting the use of these records in any criminal, civil, or administrative investigations, actions, or proceedings. The legislation increases the penalties in the event of unlawful disclosure of SUD treatment records and establishes breach notification requirements in accordance with the Health Information Technology for Economic and Clinical Health (HITECH) Act. Finally, the bill requires the Secretary of Health and Human Services to issue regulations prohibiting discrimination based on data disclosed from such medical records, to issue regulations requiring covered entities to provide written notice of privacy practices, and to develop model training programs and materials for health care providers and patients and their families. S 1354 Individual Health Insurance Marketplace Improvement Act introduced June 14, 2017 by Thomas Carper (D-DE) A bill to establish an Individual Market Reinsurance fund to provide funding for State individual market stabilization reinsurance programs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Medicare/Medicaid MMM
Medicare Advantage; Rate Notice and Call Letter; Medicare Part D; Benchmark Caps HR 6 SUPPORT for Patients and Communities Act Introduced June 13, 2018 by Greg Walden (R-OR) includes Medicaid, Medicare, and public health reforms to combat the opioid crisis by advancing treatment and recovery initiatives, improving prevention, protecting communities, and bolstering efforts to combat illicit synthetic drugs like fentanyl. The policies contained in the legislation were advanced through regular order by the House Energy and Commerce Committee and the Ways and Means Committee. HR 908, S 3497 Medicare Advantage Quality Payment Relief Act - This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid to disregard the application of certain percentage quality increases when calculating the maximum payment that may be made to a Medicare Advantage organization. HR 4952, S 3496 Improving Seniors Access to Quality Benefits Act - This bill requires the Centers for Medicare & Medicaid Services to report on how the inclusion of quality percentage increases in Programs of All-Inclusive Care for the Elderly affects certain payment calculations under Medicare Advantage.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Pharmacy PHA
Opioid Epidemic; CREATES Act; Drug Pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| GREGORY P ENGLERT | — |
| MICHAEL G WARFEL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.